Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Peroxiredoxin 4 anticorps

PRDX4 Reactivité: Humain ELISA, Coat Hôte: Souris Monoclonal CPTC-PRDX4-2 unconjugated
N° du produit ABIN6939084
  • Antigène Voir toutes Peroxiredoxin 4 (PRDX4) Anticorps
    Peroxiredoxin 4 (PRDX4)
    Reactivité
    • 53
    • 30
    • 17
    • 6
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 50
    • 7
    • 1
    • 1
    Souris
    Clonalité
    • 51
    • 8
    Monoclonal
    Conjugué
    • 35
    • 7
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Peroxiredoxin 4 est non-conjugé
    Application
    • 46
    • 28
    • 25
    • 7
    • 6
    • 6
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Coating (Coat)
    Specificité
    The peroxiredoxin (PRX) family comprises six antioxidant proteins, PRX I, II, III, IV, V and VI, which protect cells from reactive oxygen species (ROS) by preventing the metal-catalyzed oxidation of enzymes. The PRX proteins primarily utilize thioredoxin as the electron donor for antioxidation, although they are fairly promiscuous with regard to the hydroperoxide substrate. In addition to protection from ROS, peroxiredoxins are also involved in cell proliferation, differentiation and gene expression. PRX I, II, IV and VI show diffuse cytoplasmic localization, while PRX III and V exhibit distinct mitochondrial localization. The human PRX IV gene is expressed in many tissues. It exists as a precursor protein, which is only detected in testis, and aprocessed secreted form. PRX IV is highly expressed in lung cancer and is necessary for the promotion of lung cancer in vitro. Studies have demonstrated that PRX IV positive expression is significantly correlated with recurrences and shorter disease-free survival in patients with early-stage lung squamous cell carcinoma, and therefore can be used as a prognostic marker in lung squamous cell carcinoma.
    Réactivité croisée (Details)
    Human,
    Purification
    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.
    Immunogène
    Recombinant full-length human PRDX4 protein
    Clone
    CPTC-PRDX4-2
    Isotype
    IgG2b
    Top Product
    Discover our top product PRDX4 Anticorps primaire
  • Indications d'application

    Positive Control: HepG2, HeLa and Jurkat cell lysates. Ovarian carcinoma tissue.

    Known Application: ELISA (For coating, order Ab without BSA), Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    Prepared in 10 mM PBS with 0.05 % BSA and 0.05 % azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-80 °C
    Stockage commentaire
    Antibody with azide - store at 2 to 8 °C. Antibody is stable for 24 months. Non-hazardous. Also available WITHOUT BSA & azide at 1.0mg/ml.
    Date de péremption
    24 months
  • Antigène
    Peroxiredoxin 4 (PRDX4)
    Autre désignation
    PRDX4 (PRDX4 Produits)
    Synonymes
    anticorps MGC82793, anticorps prdx4, anticorps MGC79732, anticorps PRDX4, anticorps AOE37-2, anticorps PRX-4, anticorps AOE372, anticorps Prx-iv, anticorps Prx4, anticorps TRANK, anticorps fb59c09, anticorps wu:fb59c09, anticorps zgc:162938, anticorps peroxiredoxin 4, anticorps peroxiredoxin 4 L homeolog, anticorps PRDX4, anticorps prdx4.L, anticorps prdx4, anticorps Prdx4
    Sujet
    Antioxidant enzyme AOE372, EC 1.11.1.15, Thioredoxin dependent peroxide reductase A0372, TRANK,Peroxiredoxin 4 (Prognostic Marker for Lung SqCC)
    Cellular localisation: Cytoplasm. Secreted.
    Poids moléculaire
    27kDa
    ID gène
    10549, 83383
    UniProt
    Q13162
Vous êtes ici:
Support technique